Winpak Ltd. (WIPKF)
OTCMKTS · Delayed Price · Currency is USD
30.35
+0.03 (0.08%)
At close: Aug 6, 2025
Akoya Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 29, 2025 | Dec '24 Dec 29, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 25, 2022 | Dec '21 Dec 26, 2021 | Dec '20 Dec 27, 2020 | 2016 - 2020 |
| 1,128 | 1,131 | 1,141 | 1,181 | 1,002 | 852.49 | Upgrade | |
Revenue Growth (YoY) | 1.67% | -0.92% | -3.36% | 17.88% | 17.54% | -2.44% | Upgrade |
Cost of Revenue | 776.1 | 769.27 | 807.26 | 849.37 | 727.55 | 588.86 | Upgrade |
Gross Profit | 352.12 | 361.63 | 334.15 | 331.76 | 274.45 | 263.63 | Upgrade |
Selling, General & Admin | 147.55 | 147.2 | 134.13 | 133.99 | 115.6 | 100.21 | Upgrade |
Research & Development | 22.2 | 21.59 | 20.35 | 18.25 | 17.83 | 16.51 | Upgrade |
Other Operating Expenses | - | - | 0.29 | - | - | - | Upgrade |
Operating Expenses | 170.04 | 168.8 | 154.78 | 155.64 | 133.47 | 116.9 | Upgrade |
Operating Income | 182.08 | 192.83 | 179.38 | 176.13 | 140.98 | 146.73 | Upgrade |
Interest Expense | -0.5 | -0.58 | -0.47 | -0.49 | -0.52 | -0.42 | Upgrade |
Interest & Investment Income | 20.26 | 26.99 | 23.79 | 5.96 | 0.8 | 2.87 | Upgrade |
Currency Exchange Gain (Loss) | -2.93 | -4.62 | 1.53 | -3.67 | 1.27 | -0.06 | Upgrade |
Other Non Operating Income (Expenses) | -3.69 | -3.69 | -4.44 | -3.84 | -0.92 | -1.41 | Upgrade |
EBT Excluding Unusual Items | 195.22 | 210.94 | 199.79 | 174.09 | 141.61 | 147.72 | Upgrade |
Impairment of Goodwill | -1 | -1 | - | - | - | - | Upgrade |
Pretax Income | 194.22 | 209.94 | 199.79 | 174.09 | 141.61 | 147.72 | Upgrade |
Income Tax Expense | 53.56 | 58.87 | 52.2 | 45.86 | 35.27 | 38.8 | Upgrade |
Earnings From Continuing Operations | 140.66 | 151.07 | 147.59 | 128.23 | 106.35 | 108.92 | Upgrade |
Minority Interest in Earnings | -0.77 | -1.61 | 0.54 | 0.12 | -2.54 | -2.59 | Upgrade |
Net Income | 139.89 | 149.46 | 148.13 | 128.34 | 103.81 | 106.32 | Upgrade |
Net Income to Common | 139.89 | 149.46 | 148.13 | 128.34 | 103.81 | 106.32 | Upgrade |
Net Income Growth | -2.30% | 0.89% | 15.42% | 23.64% | -2.36% | -7.36% | Upgrade |
Shares Outstanding (Basic) | 62 | 64 | 65 | 65 | 65 | 65 | Upgrade |
Shares Outstanding (Diluted) | 62 | 64 | 65 | 65 | 65 | 65 | Upgrade |
Shares Change (YoY) | -3.71% | -2.13% | - | - | - | - | Upgrade |
EPS (Basic) | 2.25 | 2.35 | 2.28 | 1.97 | 1.60 | 1.64 | Upgrade |
EPS (Diluted) | 2.25 | 2.35 | 2.28 | 1.97 | 1.60 | 1.64 | Upgrade |
EPS Growth | 1.46% | 3.09% | 15.42% | 23.64% | -2.36% | -7.36% | Upgrade |
Free Cash Flow | 58.2 | 58.6 | 152.17 | 28.44 | 48.76 | 104.72 | Upgrade |
Free Cash Flow Per Share | 0.94 | 0.92 | 2.34 | 0.44 | 0.75 | 1.61 | Upgrade |
Dividend Per Share | 0.140 | 0.111 | 0.091 | 0.088 | 0.094 | 0.093 | Upgrade |
Dividend Growth | 57.05% | 22.17% | 2.88% | -5.67% | 0.42% | 1.66% | Upgrade |
Gross Margin | 31.21% | 31.98% | 29.28% | 28.09% | 27.39% | 30.92% | Upgrade |
Operating Margin | 16.14% | 17.05% | 15.72% | 14.91% | 14.07% | 17.21% | Upgrade |
Profit Margin | 12.40% | 13.22% | 12.98% | 10.87% | 10.36% | 12.47% | Upgrade |
Free Cash Flow Margin | 5.16% | 5.18% | 13.33% | 2.41% | 4.87% | 12.28% | Upgrade |
EBITDA | 235.96 | 245.36 | 228.56 | 225.09 | 187.86 | 192.65 | Upgrade |
EBITDA Margin | 20.91% | 21.70% | 20.03% | 19.06% | 18.75% | 22.60% | Upgrade |
D&A For EBITDA | 53.88 | 52.53 | 49.19 | 48.97 | 46.88 | 45.91 | Upgrade |
EBIT | 182.08 | 192.83 | 179.38 | 176.13 | 140.98 | 146.73 | Upgrade |
EBIT Margin | 16.14% | 17.05% | 15.72% | 14.91% | 14.07% | 17.21% | Upgrade |
Effective Tax Rate | 27.58% | 28.04% | 26.13% | 26.34% | 24.90% | 26.27% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.